Semaglutide vs. Tirzepatide: Which GLP-1 Weight Loss Medication Is Right for You?
Both semaglutide and tirzepatide deliver significant weight loss but they are not the same. This clinical comparison covers how each medication works, what the data shows, side effects, cost, and how to decide which is right for your goals.
If you are exploring medical weight loss in Port Saint Lucie or the Treasure Coast, you have likely encountered two medications dominating the conversation: semaglutide and tirzepatide. Both are GLP-1 receptor agonists with significant clinical weight loss data, but they are not identical.
How GLP-1 Medications Work
GLP-1 signals fullness to your brain, slows gastric emptying, and regulates blood sugar. Tirzepatide goes further by also activating GIP (glucose-dependent insulinotropic polypeptide) receptors, enhancing fat mobilization beyond GLP-1 activation alone.
Semaglutide at a Glance
- Active ingredient in Ozempic and Wegovy
- Average 15% body weight reduction over 68 weeks (STEP trials)
- Once-weekly subcutaneous injection
- FDA-approved for chronic weight management
Tirzepatide at a Glance
- Active ingredient in Mounjaro and Zepbound
- Average 20.2% body weight reduction at 72 weeks (SURMOUNT-5 trial)
- Dual GLP-1/GIP receptor activation
- FDA-approved for chronic weight management
Clinical Data Head-to-Head
The SURMOUNT-5 trial published in the New England Journal of Medicine showed tirzepatide achieved 20.2% body weight reduction versus 13.7% for semaglutide at 72 weeks. A 2025 meta-analysis confirmed tirzepatide produced an additional 4.23 kg weight loss on average. Individual results depend on adherence, lifestyle, and metabolic profile.
Side Effects
Both medications share gastrointestinal side effects: nausea, diarrhea, constipation, and decreased appetite. These are generally mild, occur during dose escalation, and improve within 4-8 weeks. Physician supervision at AVAANDI allows real-time protocol adjustments.
Cost at AVAANDI MedSpa
AVAANDI MedSpa medical weight loss programs start at $299-$399 per month including physician oversight, monitoring, and nutritional guidance. Call (772) 742-2111 or visit www.avaandi.com/medical-weight-loss to learn more.
This article is for informational purposes only. Consult a qualified healthcare provider before starting any medication.
Frequently Asked Questions
Is semaglutide or tirzepatide safer?
Both are FDA-approved with similar side effect profiles dominated by gastrointestinal symptoms. Neither is significantly safer than the other. Your provider will weigh risks based on your health history.
How quickly will I see weight loss results?
Most patients notice appetite reduction within the first 1-2 weeks. Measurable weight loss appears within the first month, with the most significant results over 6-12 months.
Do I need a prescription for GLP-1 medications?
Yes. Both semaglutide and tirzepatide are prescription medications. At AVAANDI MedSpa, your initial consultation includes a health assessment to determine if you are a candidate.
Can I combine GLP-1 medication with other AVAANDI treatments?
Yes. Many weight loss patients also benefit from IV vitamin therapy for nutrient optimization, peptide therapy for metabolic support, and hormone optimization for underlying imbalances.
How is AVAANDI different from online weight loss services?
Online services typically offer limited medical oversight. At AVAANDI MedSpa in Port Saint Lucie, you receive face-to-face consultations, ongoing monitoring, and access to complementary treatments in one clinic.
Related Services at AVAANDI MedSpa
Ready to Get Started?
Schedule a consultation at AVAANDI MedSpa in Port Saint Lucie. No referral required.
📍 1801 SE Hillmoor Dr., Suite C103, Port Saint Lucie, FL 34952 · www.avaandi.com